Todos Med Ltd (TOMDF)

[JoeForkeyBolo]

I had read the article earlier today. The 100% accuracy in the title is misleading. Reading the full article explains why. Notice that a larger trial is needed and the researchers say they need to improve sensitivity and specificity, and deal with the shortcomings of the data produced. Why are improvements needed if it's already at 100%?

While I applaud them for their approach and what is hopefully great news for Alzheimers diagnosis, they have more work to do, just like Todos with LymPro. That horse is still in the race for anyone who reads and comprehends the entire article and doesn't try to present a skewed version.